Which is Better for Weight Loss: Mounjaro or Zepbound?

Last reviewed: July 8, 2026

Last updated: July 8, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Mounjaro (tirzepatide) and Zepbound (semaglutide) are both FDA-approved GLP-1 medications for chronic weight management, but they work through different biological pathways. Clinical trials show tirzepatide produced greater average weight loss than semaglutide across comparable dosing periods. Choosing between them depends on your individual metabolic factors, response patterns, and treatment goals.

How Tirzepatide and Semaglutide Target Weight Loss Differently

Semaglutide (Zepbound) activates the GLP-1 receptor alone, signaling your brain to reduce hunger and slow stomach emptying. Tirzepatide (Mounjaro) activates both GLP-1 and GIP receptors simultaneously, creating a dual-hormone effect that may amplify appetite suppression and metabolic adjustment. This fundamental difference in mechanism explains why some patients respond more favorably to one compound over the other.

In the SURMOUNT trials, tirzepatide achieved average weight reductions of 20-22% of body weight at the highest dose, compared to semaglutide's 15-17% in STEP trials at equivalent timepoints. The additional GIP pathway engagement in tirzepatide appears to enhance insulin sensitivity and reduce overall caloric intake more robustly for many patients. However, individual variation remains significant—genetic factors influence how your body responds to each pathway.

Clinical Trial Outcomes: What the Data Shows About Each Drug

SURMOUNT-1 demonstrated that tirzepatide at the 15 mg dose produced an average weight loss of 21% over 72 weeks in adults with obesity or overweight with comorbidities. STEP-1, semaglutide's comparable trial, showed average weight reductions of 15% at the 2.4 mg dose over the same duration. Both medications significantly improved cardiometabolic markers including blood pressure, triglycerides, and HbA1c levels.

Side effect profiles overlap substantially—nausea, vomiting, and gastrointestinal discomfort occur with both—but tirzepatide may cause slightly higher rates of nausea during titration phases. Tolerability often improves within 4-8 weeks as your body adapts. The choice between medications should factor in your personal history with nausea, your metabolic baseline, and whether dual-pathway activation aligns with your genetic predispositions for GLP-1 and GIP receptor sensitivity.

How Your Genetics Relate to GLP-1 Pathways

Your DNA influences how effectively each receptor pathway works in your body. Key genetic variants like GLP1R rs6923761 and GIPR rs1800437 determine baseline sensitivity to GLP-1 and GIP signaling, respectively. If you carry variants associated with lower GLP1R function, semaglutide alone may produce a blunted response, making tirzepatide's dual activation a smarter choice.

PlexusDx Precision Peptide Genetic Test maps 14 metabolic pathways and 49 peptides across 150+ genetic insights to reveal your unique peptide-pathway profile. Understanding whether your FTO rs9939609 variant or MC4R rs17782313 status favors single- or dual-receptor activation can guide selection between tirzepatide and semaglutide from your first dose. This personalization accelerates your path to meaningful weight loss without trial-and-error switching.

Cost Comparison and Access to Tirzepatide at PlexusDx

PlexusDx offers compounded tirzepatide injection at $289/mo (or $249/mo on the 6-month plan) flat pricing, regardless of dose escalation. Your dose may need to go up. Your price won't. This contrasts sharply with branded Mounjaro, where insurance coverage is unpredictable and out-of-pocket costs often exceed $800-$1,200 monthly without coverage.

Compounded semaglutide injection from PlexusDx starts at $189/mo (or $149/mo on the 6-month plan) for those preferring the single-pathway option. Both are produced by licensed 503A compounding pharmacies, serve all 50 states without insurance requirements, and qualify for HSA/FSA funds. Adding the Precision Peptide Genetic Test ($99 after your first month) ensures your medication choice aligns with your genetic profile, maximizing efficacy and minimizing wasted months on a suboptimal compound.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $289/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Which medication causes more weight loss on average?

Tirzepatide (Mounjaro) typically produces 4-7% greater weight loss than semaglutide (Zepbound) across comparable dosing periods in clinical trials. However, individual responses vary significantly based on genetics, adherence, diet, and exercise. Some patients respond excellently to semaglutide alone, while others need tirzepatide's dual-pathway effect for meaningful results.

Can I switch from semaglutide to tirzepatide if I'm not seeing results?

Yes—if you've been on semaglutide for 8+ weeks without adequate weight loss, switching to tirzepatide is a medically sound strategy supported by the additional GIP-pathway activation. PlexusDx supports medication transitions and can incorporate genetic insights to optimize your new regimen from day one.

Is compounded tirzepatide as effective as brand-name Mounjaro?

Compounded tirzepatide from licensed 503A pharmacies contains the identical active compound as Mounjaro and delivers equivalent clinical results when produced under pharmacy quality standards. PlexusDx sources from licensed 503A compounding facilities—never 503B—ensuring purity, sterility, and potency match pharmaceutical-grade standards at a fraction of the branded cost.

What if I have a sensitivity to nausea with GLP-1 medications?

Tirzepatide may cause slightly higher initial nausea than semaglutide during dose escalation, though both typically improve within 4-8 weeks. If nausea is your primary concern, starting with semaglutide or PlexusDx's Microdose GLP-1 Protocol ($129/mo) allows a gentler titration. Your care team can adjust based on your tolerance.

How does the Precision Peptide Genetic Test help me choose between these medications?

PlexusDx Precision Peptide Genetic Test identifies your GLP1R and GIPR genetic variants, FTO obesity risk alleles, and MC4R appetite-regulation status across 14 metabolic pathways. If your genetics show lower GLP1R sensitivity but strong GIPR response, tirzepatide becomes the evidence-backed choice. The test costs $99 and informs your medication selection after your first treatment month.

Related Reading

• Mounjaro For Weight Loss 2
• Weight Loss Mounjaro
• Mounjaro Weight Loss By Week
• Wegovy Vs Zepbound Weight Loss

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.